N2 Strategic Plan November 2_V[removed]Final draft formatted

First Page		Document Content
Date: 2014-04-25 15:21:50 Science Health Clinical trial Canadian Institutes of Health Research Clinical research coordinator Clinical research Pharmaceutical industry Research		N2 Strategic Plan November 2_V[removed]Final draft formatted Add to Reading List Source URL: n2canada.ca Download Document from Source Website File Size: 3,05 MB Share Document on Facebook

	TRANSITION-TO-SCALE HEALTH IMPACT QUESTIONNAIRE This Health Impact Questionnaire will be evaluated through a scientific peer review managed independently by the Canadian Institutes of Health Research (CIHR), based on the DocID: 1sMxB - View Document
	Can Cancer Experts Accurately Forecast the Replication of Cancer Biology Experiments? Lead Investigator: Jonathan Kimmelman Co-investigators: Daniel Benjamin Funding Agency: Canadian Institutes of Health Research Term: F DocID: 1rp2G - View Document
	Challenges in Promoting RCR: Reflections from a Public Funder´s Perspective Secretariat on Responsible Conduct of Research [Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Ca DocID: 1resY - View Document
	Guidelines on Meeting the NIH Requirement for Instruction in the Responsible Conduct of Research Note: These guidelines pertain specifically to certain grant awards from the National Institutes of Health. For awards from DocID: 1r59i - View Document
	November 5, 2015 Request for Applications 2015 Bioinformatics and Computational Biology Competition 1. Overview Genome Canada, in partnership with the Canadian Institutes of Health Research (CIHR), is DocID: 1qGkn - View Document